How does Novo Nordisk's tax efficiency compare across fiscal quarters?

Novo Nordisk's tax efficiency, as measured by the tax rate, has shown a general upward trend across fiscal quarters over the past year. The tax rate for the most recent quarter ending on December 31, 2024, is 26%, which is the highest recorded during this period. The tax rate for the preceding quarter was 22%, and the one before that was 20%. This indicates a clear upward trajectory in the company's tax burden over the past year.